Christoph Mann
0000-0002-7823-8428
7 papers found
Refreshing results…
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma
Comparison of bone marrow and peripheral blood aberrant plasma cell assessment by NGF in patients with MM
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial
Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cells
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial
Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantation
Downregulation of miR-503 in Activated Kidney Fibroblasts Disinhibits KCNN4 in an <b><i>in Vitro</i></b> Model of Kidney Fibrosis
Missing publications? Search for publications with a matching author name.